Miruvor
Sign up
Long COVID Outcome unclearIll for 2 years

Long COVID with dry painful eyes; psilocybin gave brief relief, nicotine patches helped

Condition
Long COVID
At worst
Not stated
Ill for
2 years
Last post
Apr 2024
In their words
  • Condition: Long COVIDYes, dry and now painful pinguecula. Infected Jan 2022 and Nov 2023. In context ↗
  • Began after: COVIDInfected Jan 2022 and Nov 2023. In context ↗
Read from 3 of their posts and comments; links to the 3 this page draws on

Request to remove this story

Summary

Hill 18792 has had long COVID since an infection in January 2022, with dry, painful eyes that worsened after a second infection in November 2023. They reported that psilocybin gave brief, temporary relief, that nicotine patches and cannabis were also helpful, and that tolerance to patches and mushrooms built within days to a week.

Ask Miruvor AI

Asking aboutHill 18792’s story

What they tried

Their words about each treatment
  • nicotine patch · HelpedYes, 7mg patch in the morning, left on until next morning. Remarkably better sleep the first night In context ↗
  • psilocybin · Helpedpsilocybin provides a brief, temporary relief. Wonderful, but brief. In context ↗
  • cannabis · HelpedCannabis can be used daily (edibles, save your lungs). In context ↗

Their path

They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.

WhenWhat happened
Jan 2022infected with COVID, long COVID followedInfected Jan 2022 and Nov 2023. In context ↗
Nov 2023second infection worsened eye symptomsThis has gotten worse after 2nd infection. In context ↗
2024-04-13still has dry, painful pingueculaYes, dry and now painful pinguecula. In context ↗

Symptoms mentioned

Their words about their symptoms

Ask Miruvor AI

Asking aboutHill 18792’s story

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime